Skip to main content
. 2020 Dec 1;22(4):327–334. doi: 10.51893/2020.4.OA5

Table 1.

Patient data before starting respiratory extracorporeal membrane oxygenation (ECMO), for the Princess Alexandra Hospital and the Gold Coast University Hospital combined

Respiratory ECMO
Total number of cases 49
Median age (range), years 39 (18–75)
Sex, male 33 (67%)
Median weight (range), kg 90 (50–202)
Median body mass index (range) 28.7 (18.4–78.9)
Acute respiratory diagnosis group (one only per patient)
 Viral pneumonia 19 (39%)
 Bacterial pneumonia 11 (22%)
 Asthma 2 (4%)
 Trauma and burn 3 (6%)
 Aspiration pneumonitis 7 (14%)
 Other acute respiratory diagnosis 7 (14%)
 Non-respiratory and chronic respiratory diagnoses 0 (0%)
Immunocompromised 6 (12%)
Mechanical ventilation prior to ECMO
 < 48 hours 33 (67%)
 48 hours to 7 days 11 (22%)
 > 7days 5 (10%)
CNS dysfunction 11 (22%)
Acute associated non-pulmonary infection 6 (12%)
Neuromuscular blockade agents prior to ECMO 49 (100%)
NO use before ECMO 29 (59%)
HCO3 infusion before ECMO 11 (22%)
Cardiac arrest before ECMO 7 (14%)
Paco2≥ 75* 19 (39%)
Peak inspiratory pressure ≥ 42* 13 (27%)
RESP risk class Predicted mortality (%) Number of patients
 I 8% 7 (14%)
 II 24% 19 (39%)
 III 43% 11 (22%)
 IV 67% 9 (18%)
 V 82% 3 (6%)

CNS = central nervous system; HCO3 = bicarbonate; NO = nitric oxide; Paco2 = arterial partial pressure of carbon dioxide; RESP = Respiratory ECMO Survival Prediction. All patients aged > 18 years treated with ECMO for respiratory failure.

*

Worst value in 6 hours before ECMO start time. Data collected using Extracorporeal Life Support Organization (ELSO) rules in place when RESP scores were developed. Viral pneumonias with secondary bacterial infection were coded as viral pneumonia.